These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25050825)

  • 1. Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients.
    Li X; Li Y; Zhao L; Zhang D; Yao X; Zhang H; Wang YC; Wang XY; Xia H; Yan J; Ying H
    Mol Ther Nucleic Acids; 2014 Jul; 3(7):e177. PubMed ID: 25050825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel miRNA Biomarkers for Patients With Duchenne Muscular Dystrophy.
    Meng Q; Zhang J; Zhong J; Zeng D; Lan D
    Front Neurol; 2022; 13():921785. PubMed ID: 35873767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy.
    Zhang J; Meng Q; Zhong J; Zhang M; Qin X; Ni X; Ma J; He Y; Zeng D; Lan D
    Front Neurol; 2020; 11():563609. PubMed ID: 33071947
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs as serum biomarkers in Becker muscular dystrophy.
    Gagliardi D; Rizzuti M; Brusa R; Ripolone M; Zanotti S; Minuti E; Parente V; Dioni L; Cazzaniga S; Bettica P; Bresolin N; Comi GP; Corti S; Magri F; Velardo D
    J Cell Mol Med; 2022 Sep; 26(17):4678-4685. PubMed ID: 35880500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients.
    Jeanson-Leh L; Lameth J; Krimi S; Buisset J; Amor F; Le Guiner C; Barthélémy I; Servais L; Blot S; Voit T; Israeli D
    Am J Pathol; 2014 Nov; 184(11):2885-98. PubMed ID: 25194663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs as a Tool for Differential Diagnosis of Neuromuscular Disorders.
    Mousa NO; Abdellatif A; Fahmy N; El-Fawal H; Osman A
    Neuromolecular Med; 2023 Dec; 25(4):603-615. PubMed ID: 37856057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
    Trifunov S; Natera-de Benito D; Exposito Escudero JM; Ortez C; Medina J; Cuadras D; Badosa C; Carrera L; Nascimento A; Jimenez-Mallebrera C
    Front Neurol; 2020; 11():304. PubMed ID: 32373058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of circulating miRNAs in Duchenne disease: Association with muscle injury and metabolic parameters.
    Almeida-Becerril T; Rodríguez-Cruz M; Hernández-Cruz SY; Ruiz-Cruz ED; Mendoza CRS; Cárdenas-Conejo A; Escobar-Cedillo RE; Ávila-Moreno F; Aquino-Jarquin G
    Acta Neurol Scand; 2022 Nov; 146(5):512-524. PubMed ID: 36000352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker Potential of Extracellular miRNAs in Duchenne Muscular Dystrophy.
    Coenen-Stass AML; Wood MJA; Roberts TC
    Trends Mol Med; 2017 Nov; 23(11):989-1001. PubMed ID: 28988850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digital PCR quantification of miR-30c and miR-181a as serum biomarkers for Duchenne muscular dystrophy.
    Llano-Diez M; Ortez CI; Gay JA; Álvarez-Cabado L; Jou C; Medina J; Nascimento A; Jimenez-Mallebrera C
    Neuromuscul Disord; 2017 Jan; 27(1):15-23. PubMed ID: 27979502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dystromirs as serum biomarkers for monitoring the disease severity in Duchenne muscular Dystrophy.
    Zaharieva IT; Calissano M; Scoto M; Preston M; Cirak S; Feng L; Collins J; Kole R; Guglieri M; Straub V; Bushby K; Ferlini A; Morgan JE; Muntoni F
    PLoS One; 2013; 8(11):e80263. PubMed ID: 24282529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating MicroRNAs in Duchenne Muscular Dystrophy.
    Mousa NO; Abdellatif A; Fahmy N; Zada S; El-Fawal H; Osman A
    Clin Neurol Neurosurg; 2020 Feb; 189():105634. PubMed ID: 31838454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
    Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
    Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
    [No Abstract]   [Full Text] [Related]  

  • 15. Muscle-specific microRNAs as biomarkers of Duchenne Muscular Dystrophy progression and response to therapies.
    Giordani L; Sandoná M; Rotini A; Puri PL; Consalvi S; Saccone V
    Rare Dis; 2014; 2(1):e974969. PubMed ID: 26942105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum miRNAs miR-23a, 206, and 499 as Potential Biomarkers for Skeletal Muscle Atrophy.
    Wang F; Wang J; He J; Li W; Li J; Chen S; Zhang P; Liu H; Chen X
    Biomed Res Int; 2017; 2017():8361237. PubMed ID: 29214178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of muscle-specific microRNAs in serum of muscular dystrophy animal models: promising novel blood-based markers for muscular dystrophy.
    Mizuno H; Nakamura A; Aoki Y; Ito N; Kishi S; Yamamoto K; Sekiguchi M; Takeda S; Hashido K
    PLoS One; 2011 Mar; 6(3):e18388. PubMed ID: 21479190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of various muscular tissues using miRNA profiling.
    Endo K; Weng H; Naito Y; Sasaoka T; Takahashi A; Fukushima Y; Iwai N
    Biomed Res; 2013; 34(6):289-99. PubMed ID: 24389405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach.
    Florian A; Patrascu A; Tremmel R; Rösch S; Sechtem U; Schwab M; Schaeffeler E; Yilmaz A
    Front Physiol; 2018; 9():1770. PubMed ID: 30622476
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification in GRMD dog muscle of critical miRNAs involved in pathophysiology and effects associated with MuStem cell transplantation.
    Robriquet F; Babarit C; Larcher T; Dubreil L; Ledevin M; Goubin H; Rouger K; Guével L
    BMC Musculoskelet Disord; 2016 May; 17():209. PubMed ID: 27170302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.